Previous issues
-
Previous issues
Volume 29(1) Jan 2023
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Reviews Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
- Concepción Gómez-Medina, Luma Melo, David Martí-Aguado, Ramón Bataller
- Clin Mol Hepatol. 2023;29(1):1-15.
- Management of refractory ascites
- Florence Wong
- Clin Mol Hepatol. 2023;29(1):16-32.
- Wnt signaling in liver regeneration, disease, and cancer
- Gengyi Zou, Jae-Il Park
- Clin Mol Hepatol. 2023;29(1):33-50.
- Development and prognosis of hepatocellular carcinoma in patients with diabetes
- Takuma Nakatsuka, Ryosuke Tateishi
- Clin Mol Hepatol. 2023;29(1):51-64.
- Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
- Soo-Jeung Park, Young S. Hahn
- Clin Mol Hepatol. 2023;29(1):65-76.
- Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
- Clin Mol Hepatol. 2023;29(1):77-98.
- Editorials The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- Clin Mol Hepatol. 2023;29(1):99-101.
- The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
- Jeong-Ju Yoo, Sang Gyune Kim
- Clin Mol Hepatol. 2023;29(1):102-104.
- Non-invasive tests-based risk stratification: Baveno VII and beyond
- Georg Semmler, Mathias Jachs, Mattias Mandorfer
- Clin Mol Hepatol. 2023;29(1):105-109.
- Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
- Susana G Rodrigues
- Clin Mol Hepatol. 2023;29(1):110-112.
- Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
- Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
- Clin Mol Hepatol. 2023;29(1):113-117.
- New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
- Young-Suk Lim
- Clin Mol Hepatol. 2023;29(1):118-119.
- Original Articles Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
- Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):120-134.
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
- Yu Jun Wong, Chen Zhaojin, Guilia Tosetti, Elisabetta Degasperi, Sanchit Sharma, Samagra Agarwal, Liu Chuan, Chan Yiong Huak, Li Jia, Qi Xiaolong, Anoop Saraya, Massimo Primignani
- Clin Mol Hepatol. 2023;29(1):135-145.
- Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
- Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(1):146-162.
- Letters to the Editor Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Yuanbin Liu, Mingkai Chen
- Clin Mol Hepatol. 2023;29(1):163-164.
- Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Do Seon Song, U Im Chang, Jin Mo Yang
- Clin Mol Hepatol. 2023;29(1):165-167.
- Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
- Clin Mol Hepatol. 2023;29(1):168-0.
- Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Hye Won Lee
- Clin Mol Hepatol. 2023;29(1):169-170.
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Seung Min Lee, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):171-172.
- Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
- Clin Mol Hepatol. 2023;29(1):173-175.
- Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2023;29(1):176-178.
- Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(1):179-181.
- Correspondences Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
- Won Sohn, Yong-Han Paik
- Clin Mol Hepatol. 2023;29(1):182-184.
- Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(1):185-187.
- Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
- Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani
- Clin Mol Hepatol. 2023;29(1):188-190.
- Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
- Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2023;29(1):191-193.
- Snapshot Epidemiology and updated management for autoimmune liver disease
- Nae-Yun Heo, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(1):194-196.